×

New partnership uses AI to fast-track oral pill for MS depression and fatigue

Cantex Pharmaceuticals and Headlamp Health are teaming up to fast-track an oral treatment for the debilitating depression and fatigue that affects many people living with multiple sclerosis (MS). The partnership centers on the development of azeliragon, an experimental therapy. By leveraging Headlamp’s Lumus AI platform, the companies…

Aptitud mental: Fortalecer la mente como si fuera un músculo

Con frecuencia hablamos de la importancia de la salud física. Entendemos que es una parte importante de nuestro bienestar general y que existen muchas formas de apoyarla, por ejemplo: usar las escaleras en lugar del ascensor, salir a caminar a … Continue reading → Source:…

Mental Fitness: Strengthening the Mind Like a Muscle

We often talk about the importance of physical fitness. We understand that it is an important part of our overall well-being, and there are many ways to support it, such as taking the stairs instead of the elevator, going for … Continue reading → Source:…

A caregiver’s role in recognizing progressive MS

Lindsay Kelly shares how recognizing subtle symptoms and speaking up helped guide her husband’s progressive MS care. The post A caregiver’s role in recognizing progressive MS appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com

How to lead discussions about your MS treatment goals

Talking openly with your care team about your multiple sclerosis treatment goals can help personalize your care, improve symptom management, and support your long-term quality of life. Learn how to define priorities and adapt your treatment plan as your needs evolve. The post How to…

Speaking up with clarity in MS care

Aranzazu Calzadu shares how using clear, fact-based communication may help patients express urgent needs to their care team. The post Speaking up with clarity in MS care appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com

Introducing MSAA’s President and CEO, Amanda Montague 

The Multiple Sclerosis Association of America (MSAA) is extremely proud to announce the appointment of Amanda Montague, EdM, to the position of President and CEO! For more than 20 years, Ms. Montague has been a dynamic leader at MSAA, playing a vital … Continue reading → Source:…

MRI and disability scores better predict RRMS cognitive decline than blood tests

In stable relapsing-remitting multiple sclerosis (RRMS), higher physical disability scores and brain volume loss on MRI are stronger indicators of cognitive impairment than common blood biomarkers. A new study found that while blood tests often fail to reflect mental decline, MRI scans and standard disability…